Roche EU Approves Tecentriq In Combination With Avastin And Chemotherapy

Roche: EU Approves Tecentriq In Combination With Avastin And Chemotherapy

SOUTH SAN FRANCISCO (dpa-AFX) - Swiss drug major Roche Holding AG (RHHBY) announced Friday that the European Commission has approved Tecentriq in combination with Avastin and chemotherapy for the ...

More From BioPortfolio on "Roche: EU Approves Tecentriq In Combination With Avastin And Chemotherapy"